Encompass Health Corporation (NYSE: EHC) reported Q2 EPS of $0.99, $0.15 better than the analyst estimate of $0.84. Revenue for the quarter came in at $1.07 billion versus the consensus estimate of $1.02 billion.

Sees FY18 EPS of $3.45-$3.58, versus prior of $3.30-$3.45. Sees FY18 revenue of $4.2-$4.275 billion, versus prior of $4.11-$4.210 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.